Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait: What About the Risk of Falls?

NCT07108920 is registered in ClinicalTrials.gov with Hopital Nord Franche-Comte as lead sponsor.

NCT NCT07108920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07108920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait: What About the Risk of Falls?
Lead sponsor
Hopital Nord Franche-Comte
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2025
Completion date
August 1, 2026
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

botox injection, botulinum toxin injection, fall risk, rectus femoris muscle, spasticity with multiple sclerosis, stiff knee gait